{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Sensei Biotherapeutics, Inc.
Is Sensei Biotherapeutics, Inc. technically bullish or bearish?
As of June 18, 2025, the technical trend is bullish, supported by positive MACD and moving averages, despite bearish RSI readings indicating some weakness.
What does Sensei Biotherapeutics, Inc. do?
Sensei Biotherapeutics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $7 million and a market cap of $8.26 million. Key metrics include a negative P/E ratio, a debt-to-equity ratio of -1.01, and a return on equity of -87.78%.
How big is Sensei Biotherapeutics, Inc.?
As of Jun 18, Sensei Biotherapeutics, Inc. has a market capitalization of 8.26 million, with net sales of 0.00 million and a net profit of -29.02 million over the latest four quarters. The company reported shareholder's funds of 38.39 million and total assets of 46.21 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
